Titan Medical 和 Conavi Medical 宣布合并，创建一家公开上市的混合血管内成像领导者。 Titan Medical and Conavi Medical announce a merger to create a publicly-listed hybrid intravascular imaging leader.
Titan Medical Inc. 和 Conavi Medical Inc. 宣布达成合并协议，旨在创建一家公开上市、处于商业阶段的混合血管内成像领域的领导者。 Titan Medical Inc. and Conavi Medical Inc. have announced a merger agreement, aiming to create a publicly-listed, commercial-stage leader in hybrid intravascular imaging. Titan 将收购 Conavi 的所有已发行和流通股，Conavi 股东将获得 Titan 的普通股作为交换。 Titan will acquire all issued and outstanding shares of Conavi, with Conavi shareholders receiving common shares of Titan in exchange. 合并后的公司将专注于 Conavi Novasight 混合系统的商业化，该系统旨在指导常见的微创冠状动脉手术。 The combined company will focus on commercializing Conavi's Novasight Hybrid System designed to guide common minimally invasive coronary procedures.